Company Filing History:
Years Active: 2025
Title: Mina Pastagia: Innovator in Hepatitis B Treatment
Introduction
Mina Pastagia is a prominent inventor based in South San Francisco, CA (US). She has made significant contributions to the field of medicine, particularly in the treatment of viral infections. Her innovative work focuses on the development of therapeutic agents that can combat hepatitis B virus infection.
Latest Patents
Mina holds 1 patent for her groundbreaking invention titled "Toll-like receptor agonists for use in the treatment of hepatitis B." This patent provides formulations and methods for using a TLR-7 agonist to effectively treat hepatitis B virus infection. Her research has the potential to improve treatment outcomes for patients suffering from this chronic condition.
Career Highlights
Mina is currently associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and a focus on addressing unmet medical needs in the field of infectious diseases.
Collaborations
Mina has collaborated with notable colleagues, including Peter Jozef M Van Remoortere and Sean Mark Dalziel. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the pharmaceutical industry.
Conclusion
Mina Pastagia's contributions to the field of hepatitis B treatment exemplify her dedication to innovation and research. Her work not only highlights her expertise as an inventor but also underscores the importance of collaboration in advancing medical science.